Thalidomide reduces tumour necrosis factor-α production by human alveolar macrophages

Respiratory Medicine

Volumn 91, Issue 1, 1997, Pages 31-39

  Tavares, J L ^a,b   Wangoo, A ^b   Dilworth, P ^b   Marshall, B ^b   Kotecha, S ^b   Shaw, R J ^b  

^a UNIVERSIDADE DO ESTADO DO RIO DE JANEIRO   (Brazil)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; LIPOPOLYSACCHARIDE; MESSENGER RNA; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STIMULATION; CHRONIC BRONCHITIS; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; LUNG ALVEOLUS MACROPHAGE; LUNG CANCER; LUNG DISEASE; LUNG INJURY; LUNG LAVAGE; MACROPHAGE ACTIVATION; PNEUMONIA; PRIORITY JOURNAL; SARCOIDOSIS; STEROID THERAPY; TUBERCULOSIS;

EID: 0031051039     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(97)90134-7     Document Type: Article

References (32)

1. Vilcek J, Palombela V, Henriksen L et al. Fibroblast growth enhancing activity on tumor necrosis factor and its relationship to other polypeptide growth factors. J Exp Med 1986; 163: 632-643.
2. Elias J, Krol R, Fuendlich B, Sampson P. Regulation of human lung fibroblast glycosaminogly-can production by recombinant interferons, tumor necrosis factor and lymphotoxin. J Clin Invest 1988; 81: 325-330.
3. Piguet P, Collart M, Grau G, Kapanci Y, Vassali P. Tumor necrosis factor/cachetin plays a key role in bleomycin-induced pneumopathy and fibrosis. J Exp Med 1989; 170: 655-663.
4. Baughman P, Lower E. The effect of corticosteroids on methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis. Am Rev Resp Dis 1990; 142: 1268-1271.
5. Piguet P, Collart M, Grau E, Sappino A, Vassali P. Requirement of tumor necrosis factor for development of induced pulmonary fibrosis. Nature 1990; 344: 245-247.
6. Semenzato G. Tumor necrosis factor: a cytokine with multiple biological activities. Br J Cancer 1990; 61: 354-361.
7. Cembrzynska M, Szlarcz E, Inglot A, Teodorczyk J. Elevated release of tumor necrosis factor alfa and interferon gamma by bronchoalveolar lavage leukocytes from patients with bronchial asthma. Am Rev Resp Dis 1993; 147: 291-295.
8. Manonkawkeyoon S, Probe R, Moreira A, Schauf V, Kaplan G. Thalidomide inhibits the replication of human immunodeficiency virus type 1. Proc Natl Acad Sci 1993; 90: 5974-5978.
9. Keatings V, Coulby L, Barnes P, O Connor B. Increased tumor necrosis factor alfa concentrates in induced sputum following the late asthmatic response. Eur Respir J 1995; 8 (Suppl. 19): 471.
10. Pantelidis P, Southcott A, Du Bois R. Cytokine expression in fibrosing alveolitis; differential alveolar macrophage regulation. Eur Respir J 1995; 8 (Suppl. 19): 547.
11. Zheng L, Marques L, Teschler H, Bauer P, Guzman J, Costabel U. Involvement of CD 14 in spontaneous release of TNF alfa, IL-1 beta and IL-6 by alveolar macrophages in sarcoidosis. Eur Respir J 1995; 8 (Suppl. 19): 339.
12. Barnes PF, Fong SJ, Brenan PJ, Twomey PE, Mazumder A, Modlin RL. Local production of tumor necrosis factor and IFN gamma in tuberculous pleuritis. J Immunol 1990; 145: 149-154.
13. Schauf V, Rom W, Smith K et al. Cytokine gene activation and modified responsiveness to interleukin-2 in the blood of tuberculosis patients. J Infect Dis 1993; 168: 1056-1059.
14. Kaplan G. Cytokine regulation of disease progression in leprosy and tuberculosis. Immunobiol 1994; 191: 564-568.
15. Rook G, Taverne J, Leveton C, Steele J. The role of gamma-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis. Immunology 1987; 62: 229-234.
16. Kindler V, Sappino A, Grau G, Piguet P, Vassali P. The inducing role of tumour necrosis factor in the development of bactericidal grandulomas during BCG infection. Cell 1989; 56: 731-740.
17. Appelberg R, Orme I, Pinto de Souza M, Silva M. In vitro effects of interleukin 4 on interferon gamma induced macrophage activation. Immunology 1992; 76: 553-559.
18. Wallis R, Ellner J. Cytokines and tuberculosis. J Leuk Biol 1994; 55: 676-681.
19. Ogawa T, Uchida H, Kusumoto Y, Mori Y, Yamamura Y, Hamada S. Increase in tumor necrosis factor alpha and interleukin 6 secreting cells in peripheral blood mononuclear cells from subjects infected with Mycobacterium tuberculosis. Infect Immun 1991; 59: 3021-3025.
20. Strieter R, Remick D, Lynch J, Spengler R, Kunkel S. Interleukin 2-induced tumor necrosis factor alpha gene expression in human alveolar macrophages and blood monocytes. Am Rev Resp Dis 1989; 139: 335-342.
21. Gosset T, Perez T, Lassale P, Duquesnoy B, Farre J, Tonnel A. Increased tumor necrosis factor alfa secretion by alveolar macrophages from patients with rheumatoid arthritis. Am Rev Resp Dis 1991; 143: 593-597.
22. Murch S, MacDonald T, Wood L, Costelve K. Tumor necrosis factor in the bronchoalveolar secretion of infants with the respiratory distress syndrome and the effect of dexamethasone treatment. Thorax 1992; 47: 44-47.
23. Debets J, Ruers T, Van der Linden M, Van der Linden C, Bunrman W. Inhibitory effect of corticosteroids on the secretion of tumor necrosis factor by monocytes is dependent on the stimulus including TNF synthesis. Clin Exp Immunol 1989; 78: 224-229.
24. Randall T. Thalidomide has 37-year history. JAMA 1990; 263: 1474.
25. Sampaio E, Sarno E, Galilly R, Cohn Z, Kaplan G. Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med 1991; 173: 699-703.
26. Sarno E, Grau G, Vieira L, Nery J. Serum levels of tumor necrosis factor alpha and interleukin 1 beta during leprosy reactional states. Clin Exp Immunol 1991; 84: 103-108.
27. Moreira A, Sampaio E, Zmvidzinas A, Frindt P, Smith K, Kaplan G. Thalidomide exerts its inhibitory action on tumor necrosis factor by enhancing mRNA degradation. J Exp Med 1993; 177: 1675-1680.
28. Cadranel J, Philippe C, Philippe B et al. Increased expression and occupancy of receptors for tumour necrosis factor on blood monocytes from tuberculous patients. Clin Exp Immunol 1993; 94: 51-56.
29. Randall T. Thalidomide's back in the news but in more favorable circumstances. JAMA 1990; 263: 1467-1468.
30. Mchugh S, Rifkin I, Deighton J et al. The immunosuppressive drug thalidomide induces T helper cell type type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen-and antigen-stimulated human peripheral blood mononuclear cell cultures. Clin Exp Immunol 1995; 99: 160-167.
31. Han J, Thompson P, Beutler B. Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med 1990; 172: 391-394.
32. Tracey K. TNF and Mae West or: death from too much of a good thing. Lancet 1995; 345: 75-76.